Sirius Medical, a Dutch pioneer in tumor navigation technology, secures funding
Sirius Medical, a spin-off of the Netherlands Cancer Institute, secures €10 million funding.
Published on February 4, 2025
Team IO+ selects and features the most important news stories on innovation and technology, carefully curated by our editors.
Sirius Medical, a spin-off of the Netherlands Cancer Institute, secures funding to further advance its surgical marker navigation portfolio and expand its global presence. As World Cancer Day is observed, the Dutch medical device company announced securing €10 million in additional scale-up funding. This investment round was led by Invest-NL and Nextgen Ventures.
World Cancer Day highlights the ongoing fight against cancer, and Sirius Medical’s work shows its dedication to improving cancer care. The Sirius Pintuition® platform is highly praised by breast cancer surgeons worldwide, offering easy, wire-free localization for breast-conserving surgery in any hospital. This new funding will help improve the system and GPSDetect™ software, making them more user-friendly and expanding their uses. It will also strengthen sales and support growth in new markets.
“Announcing this funding milestone on World Cancer Day underscores the urgency of our mission to improve cancer care globally,”says Bram Schermers, CEO of Sirius Medical. “This funding round, in the current fundraising environment, is a clear testament to the talent of the Sirius Medical team, and the Pintuition technology that we have developed. We are proud to continue contributing to the fight against cancer and look forward to the next phase of growth for Sirius Medical. We will have more exciting news to announce soon.”
20,000 treatments worldwide
Sirius Medical is a spin-off of the Netherlands Cancer Institute, whose roots are firmly rooted in the surgical clinic. The founders saw the need and opportunity to simplify and improve localization technology for the surgical removal of breast cancers. This work resulted in Sirius Pintuition, which provides efficient tumor removal in a simple, accurate, and affordable manner. The goal is to provide accurate devices that deliver optimal patient care while remaining affordable. Sirius has developed at lightning speed and performs over 20,000 treatments worldwide in more than 200 U.S., Europe, Australia, and New Zealand centers.
Sirius Medical is a winner of the Gerard & Anton Awards.
G&A winner Sirius Medical aims to help millions of cancer patients with a magnetic seed
This week, we highlight the winners of the Gerard and Anton Awards. Today: Sirius Medical.